Cargando…
Genetically engineered vaccines for mycobacterial antigens comprising recombinant poxvirus, e.g. vaccinia virus, capable of expressing Mycobacterium leprae, Mycobacterium tuberculosis or Mycobacterium bovis antigens
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
1988
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130466/ http://dx.doi.org/10.1016/0264-410X(88)90168-5 |
| _version_ | 1783517016395612160 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7130466 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1988 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71304662020-04-08 Genetically engineered vaccines for mycobacterial antigens comprising recombinant poxvirus, e.g. vaccinia virus, capable of expressing Mycobacterium leprae, Mycobacterium tuberculosis or Mycobacterium bovis antigens Vaccine Article Published by Elsevier Ltd. 1988-10 2002-11-13 /pmc/articles/PMC7130466/ http://dx.doi.org/10.1016/0264-410X(88)90168-5 Text en © 1988 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Genetically engineered vaccines for mycobacterial antigens comprising recombinant poxvirus, e.g. vaccinia virus, capable of expressing Mycobacterium leprae, Mycobacterium tuberculosis or Mycobacterium bovis antigens |
| title | Genetically engineered vaccines for mycobacterial antigens comprising recombinant poxvirus, e.g. vaccinia virus, capable of expressing Mycobacterium leprae, Mycobacterium tuberculosis or Mycobacterium bovis antigens |
| title_full | Genetically engineered vaccines for mycobacterial antigens comprising recombinant poxvirus, e.g. vaccinia virus, capable of expressing Mycobacterium leprae, Mycobacterium tuberculosis or Mycobacterium bovis antigens |
| title_fullStr | Genetically engineered vaccines for mycobacterial antigens comprising recombinant poxvirus, e.g. vaccinia virus, capable of expressing Mycobacterium leprae, Mycobacterium tuberculosis or Mycobacterium bovis antigens |
| title_full_unstemmed | Genetically engineered vaccines for mycobacterial antigens comprising recombinant poxvirus, e.g. vaccinia virus, capable of expressing Mycobacterium leprae, Mycobacterium tuberculosis or Mycobacterium bovis antigens |
| title_short | Genetically engineered vaccines for mycobacterial antigens comprising recombinant poxvirus, e.g. vaccinia virus, capable of expressing Mycobacterium leprae, Mycobacterium tuberculosis or Mycobacterium bovis antigens |
| title_sort | genetically engineered vaccines for mycobacterial antigens comprising recombinant poxvirus, e.g. vaccinia virus, capable of expressing mycobacterium leprae, mycobacterium tuberculosis or mycobacterium bovis antigens |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130466/ http://dx.doi.org/10.1016/0264-410X(88)90168-5 |